Performance of Afirma Gene Sequencing Classifier versus Gene Expression Classifier in thyroid nodules with indeterminate cytology
Authors:
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 11 (2) , 74-78
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Performance of the Afirma genomic sequencing classifier versus gene expression classifier: An institutional experienceCancer Cytopathology, 2019
- Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid NodulesThyroid®, 2019
- Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid NodulesJAMA Surgery, 2018
- Preoperative Molecular Markers in Thyroid NodulesFrontiers in Endocrinology, 2018
- Update on Molecular Testing for Cytologically Indeterminate Thyroid NodulesArchives of Pathology & Laboratory Medicine, 2018
- The 2017 Bethesda System for Reporting Thyroid CytopathologyThyroid®, 2017
- Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid CarcinomaJAMA Oncology, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate CytologyNew England Journal of Medicine, 2012
- The Bethesda System for Reporting Thyroid Cytopathology: A Meta-AnalysisActa Cytologica, 2012